Cargando…
Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification
Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. However, the underlying role of PDCL3 in human malignant cancers, especially in ma...
Autores principales: | Peng, Zesheng, Wang, Jiajing, Tong, Shiao, Wu, Yuxi, Yi, Dongye, Xiang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050339/ https://www.ncbi.nlm.nih.gov/pubmed/37006287 http://dx.doi.org/10.3389/fimmu.2023.1128151 |
Ejemplares similares
-
The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology
por: Hugonnet, Marjolaine, et al.
Publicado: (2021) -
Multi-Omics Approaches in Immunological Research
por: Chu, Xiaojing, et al.
Publicado: (2021) -
Absence of Synaptic Regulation by Phosducin in Retinal Slices
por: Long, James H., et al.
Publicado: (2013) -
Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer
por: Gao, Zhi-Jie, et al.
Publicado: (2023) -
Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer
por: Yang, Runyu, et al.
Publicado: (2023)